Organon & Co. (OGN)
(Delayed Data from NYSE)
$19.05 USD
+0.40 (2.14%)
Updated Aug 7, 2024 04:00 PM ET
After-Market: $19.05 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OGN 19.05 +0.40(2.14%)
Will OGN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OGN
Organon (OGN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Organon (OGN) Surpasses Q2 Earnings Estimates
OGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Product Demand Likely to Aid Organon's (OGN) Q2 Earnings
Do Options Traders Know Something About Organon (OGN) Stock We Don't?
Seeking Clues to Organon (OGN) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
Other News for OGN
Origin Enterprises Executes Share Buyback
Analysts Have Conflicting Sentiments on These Healthcare Companies: Organon (OGN), Stevanato Group (STVN) and DaVita (DVA)
Bank of America Securities Keeps Their Sell Rating on Organon (OGN)
Morgan Stanley Remains a Hold on Organon (OGN)
Organon’s Mixed Performance and Cautious Outlook: A Hold Rating Justified